Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
about
Screening for prostate cancerScreening for prostate cancerIncorporation of tissue-based genomic biomarkers into localized prostate cancer clinicsReduced expression of PinX1 correlates to progressive features in patients with prostate cancer.Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemiaNovel diagnostic biomarkers for prostate cancer.Personalized management in low-risk prostate cancer: the role of biomarkers.Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 casesGuttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradationUsing molecular markers to help predict who will fail after radical prostatectomy.Genomic tests to guide prostate cancer management following diagnosis.Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy.Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.
P2860
Q24201690-B5ECDB91-A9B0-4BB0-AE90-4ED4A5CB4B7BQ24245476-69D5C778-2124-43FC-8B4D-AD85C0ABA64EQ26752510-286CB3DE-2DC6-4DD6-8FE6-EDB0427DA04BQ33762586-F8670537-1A81-48BF-80D8-024F7BF1A120Q33942256-D7CEDCF4-7984-46CF-9393-5F9AA603696FQ34231678-B9959E3C-243F-4F01-AF4C-0F326EE7BBE5Q36495701-7D7DD297-D4EE-4B39-B1C5-9B64A36544C1Q36544125-49C44E06-E486-4570-9D3B-4C75CCC420D6Q37023800-94287489-F1D3-4986-8351-730B1A0A6DBCQ37482721-276429DC-150B-480A-8133-E6EBF1BB817CQ37957896-2AF01468-5A46-4A17-9957-A7443466485AQ39170943-F6CE8761-E816-4C3A-8520-91BC014B2DF0Q40288116-40C31505-29FA-4808-BEB3-16F0092F9225Q42790681-F125F2FC-71BB-43E9-A017-2D45F191E19F
P2860
Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@ast
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@en
type
label
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@ast
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@en
prefLabel
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@ast
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@en
P2093
P2860
P1476
Ki-67 in screen-detected, low- ...... e after radical prostatectomy.
@en
P2093
Ali Khatami
Jan-Erik Damber
Jonas Hugosson
Wanzhong Wang
P2860
P356
10.1080/00365590802469543
P577
2009-01-01T00:00:00Z